Abstract
Flavopiridol, a cyclin-dependent kinase inhibitor, has promising clinical activity when combined with chemotherapy. Preclinical data indicate that flavopiridol enhances oxaliplatin- and fluorouracil (5FU)-induced apoptosis in a sequence-dependent manner. We conducted a phase I trial of flavopiridol + FOLFOX (folinic acid, 5FU, and oxaliplatin) for advanced solid tumors. Flavopiridol was administered every 2 weeks with oxaliplatin before 5FU, based on sequence-dependent growth inhibition. Flavopiridol pharmacokinetics and p53 status were evaluated. Forty-eight patients were treated on study. With dose escalation of oxaliplatin (85 mg/m(2)) and 5FU (2,400 mg/m(2)), dose-limiting toxicities included hyponatremia, thrombocytopenia, and neutropenia. 5FU was subsequently reduced to allow for dose escalation of flavopiridol. Dose-limiting toxicities with escalation of flavopiridol were nausea, vomiting, and neutropenia. The maximum tolerated dose was 70 mg/m(2) flavopiridol, 85 mg/m(2) oxaliplatin, and 1,800 mg/m(2) 5FU continuous infusion over 48 hours. Clinical activity was noted in platinum-refractory germ cell tumors: 3 of 9 (33%) evaluable patients showed a partial response on imaging and 7 of 10 (70%) had a decline in serum tumo...Continue Reading
References
Nov 18, 1992·Journal of the National Cancer Institute·G KaurE Sausville
Mar 1, 1991·Cancer·R J MotzerG J Bosl
Mar 1, 1995·Anticancer Research·M FukudaN Saijo
Dec 24, 1997·Anti-cancer Drugs·E RaymondC Gespach
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C KollmannsbergerC Bokemeyer
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary K SchwartzDavid Kelsen
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mace L RothenbergDaniel G Haller
Dec 6, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christophe TournigandAimery de Gramont
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manish A ShahGary K Schwartz
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary K Schwartz, Manish A Shah
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·M N FornierG K Schwartz
Feb 14, 2008·JAMA : the Journal of the American Medical Association·Darren R FeldmanRobert J Motzer
Apr 3, 2008·Cancer Research·Grazia AmbrosiniGary K Schwartz
Citations
Oct 13, 2010·Investigational New Drugs·Bhuvaneswari RamaswamyManisha H Shah
Mar 1, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jason J LukeGary K Schwartz
Aug 5, 2011·Drugs·Jaclyn YoongTrevor Leong
Feb 13, 2014·British Journal of Cancer·A H BeesleyU R Kees
Aug 31, 2011·Journal of Cancer Research and Clinical Oncology·Jonas Cicenas, Mindaugas Valius
Oct 12, 2010·Expert Opinion on Therapeutic Targets·Neil Johnson, Geoffrey I Shapiro
Mar 29, 2014·Expert Review of Gastroenterology & Hepatology·Salah-Eddin Al-Batran, Dominique Werner
Oct 29, 2014·Cancers·Jonas CicenasMindaugas Valius
May 30, 2015·Expert Opinion on Emerging Drugs·Bruno VincenziGiuseppe Tonini
Nov 7, 2012·Expert Opinion on Emerging Drugs·Soley Bayraktar, Caio M Rocha Lima
Aug 12, 2014·Expert Opinion on Investigational Drugs·Carmen CriscitielloGiuseppe Curigliano
Oct 10, 2015·Current Oncology Reports·Christian Daniel FankhauserPeter Karl Bode
Dec 22, 2014·Journal of Ovarian Research·Yue SongKeng Shen
Apr 1, 2016·Nature Reviews. Clinical Oncology·Ben O'LearyNicholas C Turner
Mar 10, 2015·The American Journal of Pathology·Sameh MikhailMichael J Pishvaian
Sep 7, 2013·Cancer Letters·Bin JiaZhenfeng Duan
Jun 11, 2016·Expert Opinion on Investigational Drugs·Christoph OingCarsten Bokemeyer
Jun 25, 2016·Nutrients·Lingling CuiChangqing Sun
Apr 26, 2017·The Journal of Organic Chemistry·Dávid PajtásTamás Patonay
Apr 11, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yulan ChengYuriko Mori
May 26, 2011·British Journal of Cancer·G K SchwartzP J O'Dwyer
Apr 24, 2015·Oncotarget·Moubin LinHuaguang Li
Oct 21, 2018·International Journal of Molecular Sciences·Balbina García-ReyesJohannes Lemke
Aug 7, 2019·Therapeutic Advances in Medical Oncology·Zhimin TongDipen M Maru
Mar 14, 2020·Expert Review of Anticancer Therapy·Paolo ChieffiFrancesco Esposito